Quarterly ResultMay 13, 2026, 04:18 PM
Equillium Cash $61.3M; Net Loss $(5.3)M; $35M Private Placement
AI Summary
Equillium reported a net loss of $5.3 million for Q1 2026, an improvement from $8.7 million in Q1 2025. The company significantly boosted its liquidity, with cash and cash equivalents rising to $61.3 million as of March 31, 2026, up from $30.3 million at year-end 2025, primarily due to a $35.0 million private placement. Management projects this capital will fund operations into 2029, supporting the advancement of EQ504 into a Phase 1 study by mid-2026.
Key Highlights
- Cash and cash equivalents increased to $61.3 million as of March 31, 2026.
- Net loss improved to $(5.3) million in Q1 2026 from $(8.7) million in Q1 2025.
- Completed a $35.0 million private placement in March 2026.
- Net loss per share improved to $(0.06) in Q1 2026 from $(0.24) in Q1 2025.
- Research and development expenses decreased to $2.99 million in Q1 2026.
- Net cash used in operating activities improved to $(4.3) million in Q1 2026.
- Management expects current cash to fund operations into 2029.
- Phase 1 study for EQ504 is planned to commence in mid-2026.
Price Impact
More from EQ